Login
Super Investors Invesco S&P 100 Equal Weight ETF

Invesco S&P 100 Equal Weight ETF

Invesco Exchange-traded Fund Trust · net assets $2.7B · 102 holdings as of July 31, 2026. Monthly N-PORT disclosure: the full book, not just equities.

Asset mix

EC: 99.9% · STIV: 0.1%

Financial position

Total assets
$2.7B
Total liabilities
$1.14M
Net assets
$2.7B
Assets attributable to miscellaneous securities
$0
Assets invested in controlled foreign corporations
$0
Borrowings payable within one year
$0
Payable to controlled companies within one year
$0
Payable to other affiliates within one year
$0
Other liabilities payable within one year
$0
Borrowings payable after one year
$0
Payable to controlled companies after one year
$0
Payable to other affiliates after one year
$0
Other liabilities payable after one year
$0
Payables for delayed-delivery investments
$0
Payables for standby commitments
$0
Liquidation preference of outstanding preferred stock
$0
Cash not reported in Parts C or D
$0

Monthly flows and gains

Month 1 Month 2 Month 3
Sales $16.2M $264M $31.2M
Reinvestment $0 $0 $0
Redemptions $9.99M $207M $25.9M
Net realized gain (non-derivative) $3.23M $127M $7.9M
Net unrealized appreciation (non-derivative) $106M $-111M $12.1M

The three months of the reporting period, as filed; month 3 ends July 31, 2026.

Filing details

Registrant
Invesco Exchange-traded Fund Trust
Registrant CIK
1209466
Registrant LEI
QPT4TMG79RF3UWNU0R52
Series
Invesco S&P 100 Equal Weight ETF
Series ID
S000013106
Series LEI
549300CWYWYS3J3MXN45
SEC file number
811-21265
Address
3500 Lacey Road, Suite 700, Downers Grove, US-IL, 60515, US
Phone
800-983-0903
Form
NPORT-P
Filed
September 28, 2026
Report period ends
April 30, 2027
Report month ends
July 31, 2026
Accession number
000120946626001308
Holding Value % of net assets
Rtx Corp. EC $31.7M 1.18%
Booking Holdings Inc. EC $31.4M 1.16%
Thermo Fisher Scientific Inc. EC $31.1M 1.16%
Abbott Laboratories EC $31M 1.15%
Charles Schwab Corp. (the) EC $30.8M 1.14%
Capital One Financial Corp. EC $30.8M 1.14%
Bristol-myers Squibb Co. EC $30.7M 1.14%
Mastercard Inc. EC $30.6M 1.14%
Microsoft Corp. EC $30.6M 1.13%
Jpmorgan Chase & Co. EC $29.9M 1.11%
Ge Vernova Inc. EC $29.9M 1.11%
Amazon.com, Inc. EC $29.8M 1.11%
Amgen Inc. EC $29.8M 1.11%
Bank Of America Corp. EC $29.7M 1.10%
Visa Inc. EC $29.6M 1.10%
General Electric Co. EC $29.5M 1.10%
General Dynamics Corp. EC $29.4M 1.09%
3m Co. EC $29.4M 1.09%
General Motors Co. EC $29.3M 1.09%
Bank Of New York Mellon Corp. (the) EC $29.2M 1.08%
Abbvie Inc. EC $29.2M 1.08%
Intuit Inc. EC $29.1M 1.08%
Lockheed Martin Corp. EC $29M 1.08%
U.s. Bancorp EC $29M 1.08%
Union Pacific Corp. EC $28.6M 1.06%
Merck & Co., Inc. EC $28.6M 1.06%
Emerson Electric Co. EC $28.6M 1.06%
Blackrock, Inc. EC $28.2M 1.05%
Simon Property Group, Inc. EC $28.2M 1.04%
Salesforce, Inc. EC $28.1M 1.04%
Johnson & Johnson EC $28.1M 1.04%
American Express Co. EC $28M 1.04%
Adobe Inc. EC $28M 1.04%
Gilead Sciences, Inc. EC $28M 1.04%
Starbucks Corp. EC $27.9M 1.03%
Cvs Health Corp. EC $27.8M 1.03%
Medtronic PLC EC $27.8M 1.03%
Danaher Corp. EC $27.8M 1.03%
Apple Inc. EC $27.7M 1.03%
Deere & Co. EC $27.7M 1.03%
Berkshire Hathaway Inc. EC $27.6M 1.03%
Wells Fargo & Co. EC $27.6M 1.02%
Advanced Micro Devices, Inc. EC $27.5M 1.02%
Servicenow, Inc. EC $27.4M 1.02%
Coca-cola Co. (the) EC $27.4M 1.02%
Broadcom Inc. EC $27.3M 1.01%
Philip Morris International Inc. EC $27.3M 1.01%
Home Depot, Inc. (the) EC $27.2M 1.01%
Chevron Corp. EC $27.1M 1.01%
Boeing Co. (the) EC $27M 1.00%
Exxonmobil Holdings Corp. EC $27M 1.00%
Uber Technologies, Inc. EC $26.8M 0.99%
Honeywell Aerospace Inc. EC $26.7M 0.99%
Applied Materials, Inc. EC $26.7M 0.99%
Nextera Energy, Inc. EC $26.7M 0.99%
Morgan Stanley EC $26.6M 0.99%
Goldman Sachs Group, Inc. (the) EC $26.6M 0.99%
Unitedhealth Group Inc. EC $26.6M 0.99%
Colgate-palmolive Co. EC $26.5M 0.98%
Eli Lilly And Co. EC $26.4M 0.98%

Showing top 60 of 102 holdings.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support